Approval · Notice of Compliance 10044 · 2009
NORLEVO: Notice of Compliance 10044
Issued February 19, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10044
- Date
- February 19, 2009
- Company
- Laboratoire Hra PharmaChâtillon, --, France
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dose regimen
- Therapeutic class
- Emergency contraception
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORLEVO | Not yet assigned | — |
Medicinal ingredients
- LEVONORGESTREL 0.75 MG per TAB